You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ELVN Sale Disclosure
Garland J. Scott · SEC Form 4 · Filed Oct 5, 2026
Sale
Calculated transaction value
$606.72K
Garland J. Scott Director
ELVN
Enliven Therapeutics
ELVN
Transaction date
Oct 1, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 4 days later
ELVN daily price context
Close on/before transaction
$46.21
Oct 1, 2026
First close after public filing
$42.39
Oct 6, 2026
30-day return after filing
+11.46%
Through Nov 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 13,000 shares @ $46.67
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001533228-26-000009
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$807.83K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enliven Therapeutics, Inc. ELVN | Exercise | Oct 1, 2026 | $201.11K |
| Enliven Therapeutics, Inc. ELVN | Exercise | Oct 1, 2026 | $0 |
| Enliven Therapeutics, Inc. ELVN Current | Sale | Oct 1, 2026 | $606.72K |